Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DANAHER CORP /DE/DHR · Entity 2871 | EVP | October 23, 2020 | October 27, 2020 |
| Fortive CorpFTV · Entity 3303 | Director | June 09, 2026 | June 11, 2026 |
| Veralto CorpVLTO · Entity 3203 | Director | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DANAHER CORP /DE/
Report date October 23, 2020 · Filed October 27, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 92,683 |
Ending reported balance
After 2020-10-23 transaction · row 8
8 source rows · reconciled sequenceRow 1 · 2020-10-23 · Exercise / conversion · Acquired 37,478 · Balance 130,161 Row 2 · 2020-10-23 · Sale · Disposed 14,615 · Balance 115,546 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.00 to $232.98, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Row 3 · 2020-10-23 · Sale · Disposed 4,163 · Balance 111,383 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.00 to $233.99, inclusive. Row 4 · 2020-10-23 · Sale · Disposed 8,501 · Balance 102,882 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.02 to $235.00, inclusive. Row 5 · 2020-10-23 · Sale · Disposed 8,629 · Balance 94,253 F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.03 to $235.74, inclusive. Row 6 · 2020-10-23 · Sale · Disposed 1,570 · Balance 92,683 F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.04 to $236.38, inclusive. Row 7 · 2020-10-23 · Exercise / conversion · Acquired 16,924 · Balance 109,607 Row 8 · 2020-10-23 · Sale · Disposed 16,924 · Balance 92,683 F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.95 to $232.32, inclusive. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $65.83 · Expires 2025-02-24 | Direct | 16,924 |
Reported balance
After 2020-10-23 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-10-23 · Exercise / conversion · Disposed 37,478 · Balance 16,924 F7: One half of the options granted became exercisable on each of the fourth and fifth anniversaries of the grant date, which was February 24, 2015. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $65.83 · Expires 2025-02-24 | Direct | 0 |
Reported balance
After 2020-10-23 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2020-10-23 · Exercise / conversion · Disposed 16,924 · Balance 0 F7: One half of the options granted became exercisable on each of the fourth and fifth anniversaries of the grant date, which was February 24, 2015. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 2,543 |
Reported balance
Holding disclosure · report date 2020-10-23 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 2,543 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 1,000 |
Reported balance
Holding disclosure · report date 2020-10-23 · row 10
Holding and transaction disclosures are not merged.
1 source rowRow 10 · Balance 1,000 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 38,804 |
Reported balance
Holding disclosure · report date 2020-10-23 · row 11
Holding and transaction disclosures are not merged.
1 source rowRow 11 · Balance 38,804 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.00 to $232.98, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.00 to $233.99, inclusive.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.02 to $235.00, inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.03 to $235.74, inclusive.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.04 to $236.38, inclusive.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.95 to $232.32, inclusive.
F7: One half of the options granted became exercisable on each of the fourth and fifth anniversaries of the grant date, which was February 24, 2015.
Fortive Corp
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 53,122 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 3,350 · Balance 53,122 F1: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, but, based on the election of the Reporting Person, the underlying shares will not be issued until the earlier of the Reporting Person's death or the first anniversary following the Reporting Person's retirement from the Board of Directors of the Issuer. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 1,721 |
Reported balance
Holding disclosure · report date 2026-06-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,721 |
| Common StockSEC Table I · non-derivative | IndirectThrough Irrevocable Trusts | 75 |
Reported balance
Holding disclosure · report date 2026-06-09 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 75 |
Filing footnotes · ownership attribution and instrument terms
F1: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, but, based on the election of the Reporting Person, the underlying shares will not be issued until the earlier of the Reporting Person's death or the first anniversary following the Reporting Person's retirement from the Board of Directors of the Issuer.
Veralto Corp
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,509 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 1,099 · Balance 18,509 F1: Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board. |
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $91.00 · Expires 2036-07-15 | Direct | 9,413 |
Reported balance
After 2026-07-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-15 · Grant · Acquired 3,553 · Balance 9,413 F2: The options granted to our non-employee directors will be fully vested as of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board.
F2: The options granted to our non-employee directors will be fully vested as of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 17, 2026 21:21 UTC | Veralto Corp VLTO · Entity 3203 | GrantDirector Stock Option (Right to Buy) · Derivative | 3,553 | $0.00 Strike: $91.00 | $0.00 |
DisclosureSEC source: 0001205260-26-000005 · wk-form4_1784323263.xml · derivative · entry 2 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,413 Underlying: Common Stock · 3,553 shares Expires 2036-07-15 F2 · shares: The options granted to our non-employee directors will be fully vested as of the grant date. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 21:21 UTC | Veralto Corp VLTO · Entity 3203 | GrantCommon Stock | 1,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001205260-26-000005 · wk-form4_1784323263.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,509 F1 · shares: Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 20:50 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001205260-26-000003 · wk-form4_1781211010.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,122 F1 · shares: On June 9, 2026, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2027 annual meeting of the stockholders, but, based on the election of the Reporting Person, the underlying shares will not be issued until the earlier of the Reporting Person's death or the first anniversary following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 21:10 UTC | Veralto Corp VLTO · Entity 3203 | GrantDirector Stock Option (Right to Buy) · Derivative | 2,265 | $0.00 Strike: $100.95 | $0.00 |
DisclosureSEC source: 0001967680-25-000111 · wk-form4_1752786625.xml · derivative · entry 2 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,860 Underlying: Common Stock · 2,265 shares Expires 2035-07-15 F2 · shares: The options granted to our non-employee directors will be fully vested as of the grant date. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 21:10 UTC | Veralto Corp VLTO · Entity 3203 | GrantCommon Stock | 818 | $0.00 | $0.00 |
DisclosureSEC source: 0001967680-25-000111 · wk-form4_1752786625.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,410 F1 · shares: Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date of the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board. Read SEC document |
| June 02, 2025 Filed Jun 5, 2025 00:01 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 2,140 | $0.00 Strike: $70.26 | $0.00 |
DisclosureSEC source: 0001659166-25-000086 · wk-form4_1749081702.xml · derivative · entry 4 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,140 Underlying: Common Stock · 2,140 shares Expires 2035-06-02 Read SEC document |
| June 02, 2025 Filed Jun 5, 2025 00:01 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 2,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-25-000086 · wk-form4_1749081702.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,399 F1 · shares: On June 2, 2025, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of and immediately prior to the Issuer's 2026 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the one-year anniversary of the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 22:06 UTC | Veralto Corp VLTO · Entity 3203 | GrantDirector Stock Option (Right to Buy) · Derivative | 2,005 | $0.00 Strike: $98.01 | $0.00 |
DisclosureSEC source: 0001967680-24-000084 · wk-form4_1721253993.xml · derivative · entry 2 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,595 Underlying: Common Stock · 2,005 shares Expires 2034-07-15 F2 · shares: The options granted to our non-employee directors will be fully vested as of the grant date. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 22:06 UTC | Veralto Corp VLTO · Entity 3203 | GrantCommon Stock | 842 | $0.00 | $0.00 |
DisclosureSEC source: 0001967680-24-000084 · wk-form4_1721253993.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,592 F1 · shares: Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date of the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board. Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:11 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 1,990 | $0.00 Strike: $72.95 | $0.00 |
DisclosureSEC source: 0001659166-24-000125 · wk-form4_1717632655.xml · derivative · entry 4 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,990 Underlying: Common Stock · 1,990 shares Expires 2034-06-03 Read SEC document |
| June 03, 2024 Filed Jun 6, 2024 00:11 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-24-000125 · wk-form4_1717632655.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,279 F1 · shares: On June 3, 2024, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2025 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 22:25 UTC | Veralto Corp VLTO · Entity 3203 | GrantDirector Stock Option (Right to Buy) · Derivative | 1,590 | $0.00 Strike: $73.91 | $0.00 |
DisclosureSEC source: 0001967680-23-000029 · wk-form4_1700259933.xml · derivative · entry 2 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,590 Underlying: Common Stock · 1,590 shares Expires 2033-11-15 F2 · shares: The options granted to our non-employee directors will be fully vested as of the grant date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 22:25 UTC | Veralto Corp VLTO · Entity 3203 | GrantCommon Stock | 711 | $0.00 | $0.00 |
DisclosureSEC source: 0001967680-23-000029 · wk-form4_1700259933.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,750 F1 · shares: Reflects a grant of restricted stock units that vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 22:50 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 2,310 | $0.00 Strike: $67.23 | $0.00 |
DisclosureSEC source: 0001659166-23-000164 · wk-form4_1686264646.xml · derivative · entry 4 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,310 Underlying: Common Stock · 2,310 shares Expires 2033-06-06 Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 22:50 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 2,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-23-000164 · wk-form4_1686264646.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,309 F1 · shares: On June 6, 2023, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as a portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2024 annual meeting of the stockholders, with the underlying shares to be delivered upon vesting. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:27 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 4,570 | $0.00 Strike: $63.00 | $0.00 |
DisclosureSEC source: 0001659166-22-000122 · wf-form4_165472000799344.xml · derivative · entry 4 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,570 Underlying: Common Stock · 4,570 shares Expires 2032-06-06 Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:27 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 1,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-22-000122 · wf-form4_165472000799344.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,019 F1 · shares: On June 6, 2022, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2023 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh months following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 20:54 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 2,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-21-000160 · wf-form4_162335844593624.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,509 F1 · shares: On June 8, 2021, the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2022 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first anniversary of the grant date following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 20:41 UTC | Fortive Corp FTV · Entity 3303 | GrantDirector Stock Option (Right to Buy) · Derivative | 960 | $69.44 Strike: $69.44 | $66,662.40 |
DisclosureSEC source: 0001659166-21-000140 · wf-form4_161800084606578.xml · derivative · entry 4 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 960 Underlying: Common Stock · 960 shares Expires 2031-04-07 Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 20:41 UTC | Fortive Corp FTV · Entity 3303 | GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001659166-21-000140 · wf-form4_161800084606578.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,984 F2 · price: Restricted stock units are payable in shares of common stock on a one-to-one basis. F1 · acquired: On April 7, 2021 the Issuer granted to the Reporting Person restricted stock units ("Annual Grant RSUs") of the Issuer in the amount indicated as prorated portion of the annual equity grant made to the Reporting Person. Since the Annual Grant RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of the Issuer's 2021 annual meeting of the stockholders, but the underlying shares will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following the Reporting Person's retirement from the Board of Directors of the Issuer. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 21:13 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 16,924 | $0.00 Strike: $65.83 | $0.00 |
DisclosureSEC source: 0000313616-20-000145 · edgar.xml · derivative · entry 13 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,924 shares Expires 2025-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One half of the options granted became exercisable on each of the fourth and fifth anniversaries of the grant date, which was February 24, 2015. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 21:13 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 37,478 | $0.00 Strike: $65.83 | $0.00 |
DisclosureSEC source: 0000313616-20-000145 · edgar.xml · derivative · entry 12 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,924 Underlying: Common Stock · 37,478 shares Expires 2025-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One half of the options granted became exercisable on each of the fourth and fifth anniversaries of the grant date, which was February 24, 2015. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 21:13 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 16,924 | $232.11 | $3,928,145.02 |
DisclosureSEC source: 0000313616-20-000145 · edgar.xml · nonDerivative · entry 8 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,683 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.95 to $232.32, inclusive. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 21:13 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionCommon Stock | 16,924 | $65.83 | $1,114,106.92 |
DisclosureSEC source: 0000313616-20-000145 · edgar.xml · nonDerivative · entry 7 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 21:13 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 1,570 | $236.25 | $370,907.79 |
DisclosureSEC source: 0000313616-20-000145 · edgar.xml · nonDerivative · entry 6 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,683 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.04 to $236.38, inclusive. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 21:13 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 8,629 | $235.33 | $2,030,679.83 |
DisclosureSEC source: 0000313616-20-000145 · edgar.xml · nonDerivative · entry 5 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,253 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.03 to $235.74, inclusive. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 21:13 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 8,501 | $234.46 | $1,993,178.46 |
DisclosureSEC source: 0000313616-20-000145 · edgar.xml · nonDerivative · entry 4 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,882 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.02 to $235.00, inclusive. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 21:13 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 4,163 | $233.57 | $972,347.75 |
DisclosureSEC source: 0000313616-20-000145 · edgar.xml · nonDerivative · entry 3 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,383 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.00 to $233.99, inclusive. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 21:13 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 14,615 | $232.21 | $3,393,778.38 |
DisclosureSEC source: 0000313616-20-000145 · edgar.xml · nonDerivative · entry 2 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,546 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.00 to $232.98, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 21:13 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionCommon Stock | 37,478 | $65.83 | $2,467,176.74 |
DisclosureSEC source: 0000313616-20-000145 · edgar.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 11, 2020 21:06 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GiftCommon Stock | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000313616-20-000139 · edgar.xml · nonDerivative · entry 2 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,683 Read SEC document |
| August 04, 2020 Filed Aug 11, 2020 21:06 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | GiftCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000313616-20-000139 · edgar.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,183 Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 3,540 | $201.53 | $713,416.20 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 15 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,933 F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.20 to $201.74, inclusive. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 4,460 | $200.34 | $893,520.86 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 14 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,473 F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.03 to $200.82, inclusive. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 58,978 | $0.00 Strike: $56.70 | $0.00 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · derivative · entry 20 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,978 shares Expires 2024-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: One third of the options granted became exercisable on each of the third, fourth and fifth anniversaries of the grant date, which was May 15, 2014. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $65.83 | $0.00 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · derivative · entry 19 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,402 Underlying: Common Stock · 30,000 shares Expires 2025-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: One half of the options granted became exercisable on each of the fourth and fifth anniversaries of the grant date, which was February 24, 2015 Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 3,054.189 | $195.27 | $596,391.49 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 13 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Indirect · By 401k Disclosed balance after: 0 F11 · shares: The reporting person completed an intra-fund transfer of 3,054.189 shares in the 401(k) plan, from the Danaher Corporation common stock fund to another investment fund, and, as a result, no longer holds any indirect securities in his 401k. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 16,821 | $195.10 | $3,281,777.10 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 12 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,933 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.86 to $195.52, inclusive. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 18,085 | $194.40 | $3,515,687.83 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 11 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,754 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.86 to $194.85, inclusive. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 13,160 | $193.44 | $2,545,617.76 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 10 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,839 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.86 to $193.85, inclusive. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 8,312 | $192.47 | $1,599,818.95 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 9 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,999 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.85 to $192.84, inclusive Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 2,600 | $190.99 | $496,576.60 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 8 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,311 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.53 to $191.52, inclusive. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionCommon Stock | 58,978 | $56.70 | $3,344,052.60 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 7 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 9,505 | $195.07 | $1,854,149.86 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 6 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,933 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.81 to $195.48, inclusive. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 8,790 | $194.32 | $1,708,072.80 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 5 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,438 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.81 to $194.80, inclusive. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 6,890 | $193.36 | $1,332,257.29 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 4 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,228 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.79 to $193.76, inclusive. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 3,615 | $192.39 | $695,500.70 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 3 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,118 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.78 to $192.76, inclusive. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 1,200 | $190.99 | $229,192.80 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 2 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,733 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.53 to $191.52, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:12 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | Exercise / conversionCommon Stock | 30,000 | $65.83 | $1,974,900.00 |
DisclosureSEC source: 0000313616-20-000124 · edgar.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:11 UTC | DANAHER CORP /DE/ DHR · Entity 2871 | SaleCommon Stock | 18,259 | $165.68 | $3,025,078.08 |
DisclosureSEC source: 0000313616-20-000100 · edgar.xml · nonDerivative · entry 1 COMAS DANIEL L · CIK 0001205260 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,933 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.28 to $166.08, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.